LineLabelWBD-PValueSourceMessage
1Dimensions period from 2001-01-01 to 2001-12-31 for SAMP Scenario-1
2U-Monetary
3company:By Product (Placeholder)//products:All Products
4ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF32,465,000bothOK
5ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF10,137,000inst 
6ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF10,396,000inst 
7ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF3,210,000inst 
8ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF8,722,000inst 
 
9company:By Region (Placeholder)//regions:All Regions
10ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF32,465,000bothOK
11ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF15,275,000inst 
12ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF1,823,000inst 
13ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF5,752,000inst 
14ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF9,615,000inst 
 
15Dimensions period from 2002-01-01 to 2002-12-31 for SAMP Scenario-1
16U-Monetary
17company:By Product (Placeholder)//products:All Products
18ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF35,805,000bothOK
19ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF12,649,000inst 
20ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF10,374,000inst 
21ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF4,371,000inst 
22ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF8,411,000inst 
 
23company:By Region (Placeholder)//regions:All Regions
24ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF35,805,000bothOK
25ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF18,150,000inst 
26ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF1,973,000inst 
27ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF6,514,000inst 
28ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF9,168,000inst 
 
29Dimensions period from 2003-01-01 to 2003-12-31 for SAMP Scenario-1
30U-Monetary
31company:By Product (Placeholder)//products:All Products
32ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF32,038,000bothOK
33ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF10,214,000inst 
34ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF11,901,000inst 
35ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF5,639,000inst 
36ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF4,284,000inst 
 
37company:By Region (Placeholder)//regions:All Regions
38ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF32,038,000bothOK
39ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF20,181,000inst 
40ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF2,433,000inst 
41ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF6,675,000inst 
42ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF2,749,000inst 


Contexts
IDD-2003-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-Pharm
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2002-Pharm
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2001-Pharm
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2003-Gen
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2002-Gen
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2001-Gen
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2003-ConHealth
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2002-ConHealth
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2001-ConHealth
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2003-OtherSeg
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2002-OtherSeg
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2001-OtherSeg
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2003-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:All Products


Extended Links
ID
RoleDefault Link [http://www.xbrl.org/2003/role/link]
ID
RoleHypercube [http://www.SampleCompany.com/Hypercube]
ID
RolePrimaryConcepts [http://www.SampleCompany.com/PrimaryConcepts]


Units
IDU-Monetary
Measure<measure>iso4217:EUR</measure>


Performance Statistics
(seconds)
DTS grammars cached0
XML Validation0.0400576
Numeric context period checks0
Build calculation tree graph0
Evaluate formula dependency0
Evaluate required and essence-aliased facts0.0300432
Calculation tree roll-ups pass 10
Independent formula execution 0
Begin dimension rollup validation0
... Sales roll-ups pass 10.150216
Update displayed instance0
FRIS duplicates check0
Finish0

Product version: 6.403.2221.19361 (2006-01-30 11:45)

Software and look and feel © 2002-2006
Universal Business Matrix, inc (UBmatrix)
803 Kirkland Avenue, Suite 200
Kirkland, Washington, USA 98033-6318